Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 122 for “"Complete remission"”.
-
Time spent in complete remission (CR) and overall survival (OS) in AML patients.
Time spent in complete remission (CR) and overall survival (OS) in AML patients.
-
Οι εφαρμογές της κυτταρομετρίας ροής στις πλασματοκυτταρικές δυσκρασίες
… transplantation for all patients who achieve remission, and based on current data, it is administered until disease progression. However, a subgroup of patients achieves deep remissions, and in these patients the benefit of maintenance therapy is questionable. It is therefore important to be …
-
Clinical outcomes in patients with pemphigus vulgaris receiving a combination rituximab and intravenous immunoglobin therapy protocol
… the CD20 B cell marker, has helped induce a complete remission in subjects off all systemic therapy and decrease the morbidity of the disease. However, a small subset of patients with pemphigus vulgaris is unresponsive to all therapies. The advent of a rituximab and IVIg combination therapy …
-
Outcome of Severe Aplastic Anemia Treated with Immunosuppressive Therapy Compared with Bone Marrow Transplantation
… BMT. In the IST group, response rate was 77.8%(2 complete remission, 12 partial remission) and there were two treatment failures. As later complications, acute myeloid leukemia developed in 1 patient and myelodysplastic syndrome developed in 2 patients. In the BMT group, response rate was 92.0%(18 …
-
Body mass index and response to neoadjuvant chemotherapy in Korean breast cancer
… We studied the relationship between pathological complete remission, survival and BMI. MATERIALS AND METHODS: This study is a retrospective study through chart review who received NAC at the Ajou University Hospital from 2001 to 2013. Total 217 patients were enrolled, of which 170 patients who …
-
Μοριακή μελέτη της απόπτωσης των λευχαιμικών κυττάρων σε ηλικιωμένους ασθενείς με οξεία μυελογενή λευχαιμία
… cytotoxic chemotherapy is associated with a low complete response rate and a high treatment-related mortality in older patients, which explains in large part the poorer outcomes observed in individuals over 60 years of age. For that reason, treatment for the elderly AML patients should be based …
-
Venetoklakso ir IDH inhibitorių derinių klinikinis pritaikomumas gydant refrakterią/recidyvavusią ūminę mieloleukemiją su IDH 1/2 mutacijomis: atvejų analizė ir literatūros apžvalga /
… regimens, with triplet therapies showing higher complete remission rates (up to 83%). Comparable patient groups were identified based disease stage (newly diagnosed or relapsed/refractory AML), and IDH mutation status, enabling a descriptive statistical comparison of outcomes while avoiding …
-
Leukemia Stem Cell Markers And Inv(16) In Acute Myeloid Leukemia
… leukemia patients are able to achieve first complete remission after anthracycline- and cytarabine-based therapy, only about 60% of patients survive the disease long-term due to relapsed disease or treatment-related mortality. Multiple studies have shown that acute myeloid leukemia is …
-
Ablative Treatment With Autologous Bone Marrow Transplantation for Acute Myeloid Leukaemia
… increase in the proportion of patients entering complete remission. There has been less progress in devising appropriate post-remission therapy, with the result that there is a continuous risk of disease recurrence with most patients dying from their disease within five years. For a minority of …
-
ΕΞΩΛΕΜΦΑΔΕΝΙΚΑ ΜΗ-HODGKIN'S ΛΕΜΦΩΜΑΤΑ. ΣΥΧΝΟΤΗΤΑ-ΚΛΙΝΙΚΟΕΡΓΑΣΤΗΡΙΑΚΗ ΑΝΑΛΥΣΗ-ΠΡΟΓΝΩΣΤΙΚΟΙ ΠΑΡΑΓΟΝΤΕΣ. ΣΥΓΚΡΙΣΗ ΜΕ ΤΑ ΛΕΜΦΑΔΕΝΙΚΑ ΜΗ-HODGKIN'S ΛΕΜΦΩΜΑΤΑ
… PROCEDURE AFTER TREATMENTS SHOWED 119 PATIENTSIN COMPLETE REMISSION (82,1%). THE 36/119 RELAPSED (30,2%) AND 20/36 WITH A DISTANT EXTRANODAL INVOLVEMENT. FACTORS OF PROGNOSTIC SIGNIFICANCE FOR SURVIVAL WERE THE STAGE, THE HISTOLOGICAL TYPE AND THE SITE LOCATION OF THE EN-NHL. THE SURVIVAL RATE AT …
-
Statistical Methods for Acute Myeloid Leukemia Research: From Cell to Population
… (MRD) is a biomarker for patients with AML in complete remission that is associated with clinical outcomes. Flow cytometry-based MRD detection has been widely adopted in clinical setting, with the limitation of uncontrolled variability in measurement and interpretation across institutions. We …
-
Υποδοχέας της φωσφολιπάσης Α2 και συσχέτισή του με την κλινική πορεία ασθενών με ιδιοπαθή μεμβρανώδη σπειραματονεφρίτιδα
… with the achievement of partial compared to complete remission (p=0.02). Furthermore, anti-PLA2R levels were positively correlated with proteinuria levels at the end of a 5-year follow up (p=0.0002). Ιn the subgroup of PLA2R-positive patients at diagnosis, higher antibody levels were …
-
Immune Landscape of early liver metastatic lesions in a Novel Immunocompetent Murine Colorectal Cancer Metastasis Model
… Treatment of micro-metastases resulted in complete remission of microscopic disease and eradication of macrophages expressing CD163+ after four weeks of treatment. However, anti-CSF1R treatment did not exhibit efficacy in treating macro-metastases. Spatial transcriptomic analysis, along …
-
Retrospective Flow Cytometric Data Review of Classic Hodgkin Lymphoma Cases to Explore Disease Outcomes
… of the TME varied between patients who achieved complete remission compared to those who relapsed or whose disease had progressed. The T-cell rosetted fraction of Hodgkin-Reed Sternberg (HRS) cells showed a significant correlation to outcome. However, the %CD20 B-cells, %CD5 T-cells, %HRS cells, …
-
CAR-T cell therapy for liver metastases
… effects. Not only this, CAR-Ts have also lead to complete remission in some liquid tumors while maintaining the potential for remission in solid tumors as well. This literature review takes readers through the emergence of the different generations of CAR-T and the various studies including …
-
Ensaio clínico duplo-cego controlado e randômico, comparando a eficácia da Clofazimina com a Cloroquina, no tratamento das lesões cutâneas do Lúpus Eritematoso Sistêmico
… 6. RESULTS: Thirty-three patients began and 27 completed the 6 months of treatment. The groups were homogeneous and comparable in terms of demographic and clinical characteristics. Five CFZ-patients and one CDP-patients dropped out due to severe flare of disease requiring other treatment. At the …
-
Real-world outcomes in elderly ALL patients with and without allogeneic hematopoietic stem cell transplantation: a single-center evaluation over 10 years
… was feasible in 65.2% of EP and resulted in complete remission in 86.7% compared to 88.0% in younger patients (YP) of less than 60 years. Early death occurred in 6.7% of EP. Three-year overall survival (OS) for Ph - B-ALL was significantly worse for EP (n = 16) than YP (n = 64) with 30.0% vs …
-
Tenosinovitis infecciosa por Mycobacterium Tuberculosis
… of antituberculosis medications, achieving complete remission of his symptoms without sequelae.
-
Combined modeling of bulk and single-cell genome sequencing data to dissect clonal heterogeneity in acute myeloid leukemia
… leukemia patients with samples at diagnosis, complete remission and relapse. Using this method, I was able to reconstruct tumor development including somatic variants, somatic copy-number alterations and fusion genes from a single tumor sample and, if available, from merged diagnosis and …
-
Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations
… autologous HSCT, respectively. One patient in complete remission (CR)1 and five with advanced disease received two HSCT. Four of the six patients maintained/achieved CR for a median of 13 months. Three died of progression and one of NRM. Two patients had a third HSCT and one survived in CR +231 …
Page 1 of 7